日本輸血学会雑誌
Online ISSN : 1883-8383
Print ISSN : 0546-1448
ISSN-L : 0546-1448
血漿分画製剤の安全性に関する検討
III. 人血清アルブミン製剤 (赤十字アルブミン®, 赤十字アルブミン25®) のパスツリゼーション処理 (60℃, 10時間) によるウイルスの不活化効果の検討
室塚 剛志武田 芳於泉 浩業村井 活史白川 幸子江村 博行脇坂 明美松本 脩三藤井 暢弘
著者情報
ジャーナル フリー

1999 年 45 巻 3 号 p. 362-365

詳細
抄録

We investigated virus inactivation by two albumin products (Sekijyuji Albumin® and Sekijyuji Albumin 25® derived from human plasma with heat treatment at 60°C in liquid-phase (pasteurization) using several enveloped and non-enveloped viruses as marker viruses. Enveloped viruses were sindbis virus (SIN), vesicular stomatitis virus (VSV), herpes simplex virus type-1 (HSV-1) and human immunodeficiency virus type-1 (HIV-1). Non-enveloped viruses were polio virus (Polio V) and hepatitis A virus (HAV). The infectivity of all viruses except HAV was lost after 1hr heating, with logarithmic reduction value (LRV) for SIN, VSV, HSV-1, HIV-1 and Polio V of >5.1, >5.7, >4.3, >3.8 and >5.9, respectively. No significant difference in LRVs were observed between the two products. The infectivity of HAV, however, remained at 104.2-5.0 TCID50 even after 10hr heating and LRV stayed in the range of 1.9 to 2.7.

著者関連情報
© 日本輸血・細胞治療学会
前の記事 次の記事
feedback
Top